Evidence map›Paper›PMID 32526476›Full record

ArticleMolecular therapy. Nucleic acids2020

circCYFIP2 Acts as a Sponge of miR-1205 and Affects the Expression of Its Target Gene E2F1 to Regulate Gastric Cancer Metastasis.

Jing Lin, Shasha Liao, E Li, Zewa Liu, Ruihua Zheng, Xiaohua Wu, Wanting Zeng

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. NBioengineered · 2021
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Circular RNA in tumor metastasis.Molecular therapy. Nucleic acids · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jing LinThe First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China. Electronic address: drdingwei66@163.com.
Shasha LiaoThe First Affiliated Hospital of Shantou University Medical College, Longhu People's Hospital Shantou, Shantou 515041, China.
E LiThe First Affiliated Hospital of Shantou University Medical College, Longhu People's Hospital Shantou, Shantou 515041, China.
Zewa LiuThe First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.
Ruihua ZhengThe First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.
Xiaohua WuThe First Affiliated Hospital of Shantou University Medical College, Longhu People's Hospital Shantou, Shantou 515041, China.
Wanting ZengUniversity College, London, UK.
Shantou University · CNFirst Affiliated Hospital of Shantou University Medical College · CNUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence suggested that circular RNAs (circRNAs) play critical roles in the initiation and progression of malignant cancers. However, the roles of circRNAs in gastric cancer (GC) remain largely unknown. In the present study, we investigated the expression of circRNAs in 5 GC tissues with metastasis and 5 GC tissues without metastasis by microarray analysis. We focused on hsa_circ_0003506, which was spliced from CYFIP2 gene located at chr5:156786012-156788606 and finally formed a sense-overlapping circular transcript of 366 nt, and thus we named it circCYFIP2. circCYFIP2 was found to be significantly upregulated in GC tissues and cell lines. High expression of circCYFIP2 was associated with metastasis and poor prognosis of GC patients. Function assays revealed that overexpression or knockdown of circCYFIP2 significantly enhanced or reduced GC cell proliferation and invasion abilities. In mechanism, we found that circCYFIP2 might serve as a competing endogenous RNA (ceRNA) of microRNA-1205 (miR-1205) in GC progression. Besides, E2F1 was found to be a target of miR-1205. Collectively, our findings suggested that circCYFIP2 might serve as an oncogenic circRNA to promote GC progression via the miR-1205/E2F1 axis, which provided a potential therapeutic target for the treatment of GC.

Indexed as

ceRNAcircCYFIP2circRNAsGCmiR-1205

Identifiers

PMID32526476
PMCPMC7286931
OpenAlexW3025791298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.